4.4 Article

Likely effect of the 2014 Ebola epidemic on HIV care in Liberia

期刊

AIDS
卷 29, 期 17, 页码 2347-2351

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAD.0000000000000821

关键词

Ebola; epidemic; HIV; Liberia

资金

  1. ESTHER France

向作者/读者索取更多资源

Objective: Liberia's health system has been severely struck by the 2014 Ebola epidemic. We aimed to assess the potential effect of this epidemic on the care of HIV patient in two clinics [John F. Kennedy (JFK) and Redemption Hospitals] in Monrovia, which stayed open throughout the epidemic.Design and methods: A preexisting electronic database of HIV patient's follow-up visits was used to estimate three weekly parameters from January 2012 to October 2014: number of visits, number of new patient, and proportion of patients with follow-up delay. We used segmented negative binomial regressions to assess trends before and after the week of the Ebola outbreak defined in June 2014 by WHO.Results: The cumulative number of patients in care comprised 5948 patients with a total of 56287 visits between January 2012 and October 2014. From June 2014, the number of visit per week, stable since 2012, abruptly decreased (59%) in Redemption (P<0.001) and progressively decreased by 3% per week in JFK (P<0.001). In both the clinics, the weekly proportion of patient with follow-up delay sharply increased after the point break from June 2014 (P value < 0.001). From June 2014, a significant decrease in new patients per week occurred in both the clinics: by 57% (P value < 0.001) in Redemption and by 4.6% per week (P value < 0.001) in JFK.Conclusion: The Ebola epidemic had a significant effect on HIV care in Monrovia. Given the particular impact on the rate of patients with follow-up delay, a long-term impact is feared.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

T cell apoptosis characterizes severe Covid-19 disease

Sonia Andre, Morgane Picard, Renaud Cezar, Florence Roux-Dalvai, Aurelie Alleaume-Butaux, Calaiselvy Soundaramourty, Andre Santa Cruz, Ana Mendes-Frias, Clarisse Gotti, Mickael Leclercq, Alexandre Nicolas, Alexandra Tauzin, Alexandre Carvalho, Carlos Capela, Jorge Pedrosa, Antonio Gil Castro, Lucy Kundura, Paul Loubet, Albert Sotto, Laurent Muller, Jean-Yves Lefrant, Claire Roger, Pierre-Geraud Claret, Sandra Duvnjak, Tu-Anh Tran, Gina Racine, Ouafa Zghidi-Abouzid, Pierre Nioche, Ricardo Silvestre, Arnaud Droit, Fabrizio Mammano, Pierre Corbeau, Jerome Estaquier

Summary: By comparing COVID-19 patients with healthy donors, the study found a strong correlation between T cell apoptosis and lymphopenia in severe cases. The plasma levels of soluble FasL (sFasL) and T cell surface expression of Fas/CD95 were positively correlated with T cell death and CD4 T cell counts. The study also identified modulations in the Bcl-2 family and demonstrated the potential of a pan-caspase inhibitor, Q-VD, to prevent T cell apoptosis and enhance Th1 transcripts.

CELL DEATH AND DIFFERENTIATION (2022)

Review Infectious Diseases

Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review

Simon Galmiche, Liem Binh Luong Nguyen, Eric Tartour, Xavier de Lamballerie, Linda Wittkop, Paul Loubet, Odile Launay

Summary: This article systematically reviews the immunogenicity, efficacy, and effectiveness of COVID-19 vaccines in immunocompromised populations. The results highlight the risk of low immunogenicity in solid organ transplant recipients and patients with hematological malignancy. Enhanced vaccine regimens may be necessary despite the lack of vaccine effectiveness data.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Article Immunology

Overexpression of IgG2 in patients resembling IgG4-related disease with normal IgG4

Mathilde Lecuit, Pierre Aucouturier, Aicha Abbas, Jacques Cadranel, Christine Silvain, Jean-Marie Berthelot, Anne-Laure Fauchais, Paul Loubet, Claude Bachmeyer, Francoise Montravers, Antoine Dossier, Hilario Nunes, Pascale Cervera, Paul Coppo

Summary: IgG4-related disease is characterized by tissue infiltration leading to fibrosis and organomegaly, with clinical presentation varying widely. High serum IgG4 concentration, previously considered a diagnostic hallmark, may not always be present in patients. Elevated IgG2, IgG1, and IgG3 levels were observed in some cases, underscoring the complexity of diagnosing IgG4-RD.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2022)

Editorial Material Infectious Diseases

What a second booster dose of mRNA COVID-19 vaccines tells us

Paul Loubet, Odile Launay

LANCET INFECTIOUS DISEASES (2022)

Article Immunology

Low perforin expression in CD8+T lymphocytes during the acute phase of severe SARS-CoV-2 infection predicts long COVID

Lucy Kundura, Renaud Cezar, Sonia Andre, Mauricio Campos-Mora, Claire Lozano, Thierry Vincent, Laurent Muller, Jean-Yves Lefrant, Claire Roger, Pierre-Geraud Claret, Sandra Duvnjak, Paul Loubet, Albert Sotto, Tu-Ahn Tran, Jerome Estaquier, Pierre Corbeau

Summary: T cell cytotoxicity, specifically the expression of perforin, may play a role in determining acute disease severity and the onset of long COVID in patients with SARS-CoV-2 infection. However, perforin expression is not correlated with disease severity or predictive of death. The percentage of perforin-positive T8 cells in the acute phase of the disease may predict the occurrence of long COVID.

FRONTIERS IN IMMUNOLOGY (2022)

Article Hematology

Prognostic value of an automated thrombin generation assay in COVID-19 patients entering hospital: A multicentric, prospective observational study

Jean-Christophe Gris, Florence Guillotin, Taissa Pereira dos Santos, Mathias Chea, Paul Loubet, Didier Laureillard, Albert Sotto, Laurent Muller, Saber Davide Barbar, Claire Roger, Jean-Yves Lefrant, Boris Jung, Kada Klouche, Thibault Mura, Isabelle Quere, Antonia Perez-Martin

Summary: In this study, thrombin generation assays were performed on severe COVID-19 patients, and it was found that these assays could not predict the early or late survival rates of the patients, nor were they associated with thrombotic events. However, by detecting the changes in endogenous thrombin potential (ETP), it was possible to predict whether patients would need to be transferred to an intensive care unit in the future.

THROMBOSIS RESEARCH (2023)

Article Multidisciplinary Sciences

Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years

Christine Durier, Laetitia Ninove, Maeva Lefebvre, Anne Radenne, Corinne Desaint, Jacques Ropers, Rebecca Bauer, Said Lebbah, Diane Carette, Marie Lachatre, Anne-Sophie Lecompte, Dominique Deplanque, Elisabeth Botelho-Nevers, Anne Conrad, Bertrand Dussol, Zoha Maakaroun-Vermesse, Giovanna Melica, Jean-Francois Nicolas, Renaud Verdon, Jacques Kiladjian, Paul Loubet, Catherine Schmidt-Mutter, Christian Duale, Severine Ansart, Stephane Priet, Axel Levier, Diana Molino, Louis-Victorien Vieillard, Beatrice Parfait, Jean-Daniel Lelievre, Eric Tartour, Xavier de Lamballerie, Odile Launay

Summary: The immune response generated by a COVID-19 vaccine booster against delta and omicron variants was evaluated in 65 adults (aged 65-84) shortly after receiving the first booster dose. The study showed an increase in SARS-CoV-2 neutralizing antibodies in individuals who had not been previously infected, regardless of age, while a smaller increase was observed in those who had been infected before receiving a single dose of the primary vaccine. It is important to note that the humoral response was only observed starting from the 5th day after the booster dose.

SCIENTIFIC REPORTS (2022)

Article Immunology

Last resort beta-lactam antibiotics for treatment of New-Delhi Metallo-Beta-Lactamase producing Enterobacterales and other Difficult-to-Treat Resistance in Gram-negative bacteria: A real-life study

Romaric Larcher, Paul Laffont-Lozes, Claire Roger, Regine Doncesco, Celine Groul-Viaud, Aurelie Martin, Paul Loubet, Jean-Philippe Lavigne, Alix Pantel, Albert Sotto

Summary: This study described the use of last resort beta-lactam antibiotics in hospitalized patients and evaluated the microbiological and clinical outcomes. The results showed that the use of these antibiotics in real-life settings was a safe and efficient therapeutic option for severe infections caused by Gram-negative bacteria with Difficult-to-Treat Resistance.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Public, Environmental & Occupational Health

Clinical factors associated with peripherally inserted central catheters (PICC) related bloodstream infections: a single centre retrospective cohort

Koko Barrigah-Benissan, Jerome Ory, Claire Simon, Paul Loubet, Aurelie Martin, Jean-Paul Beregi, Jean-Philippe Lavigne, Albert Sotto, Romaric Larcher

Summary: This study aimed to assess the clinical factors associated with peripherally inserted central catheter (PICC)-related bloodstream infections (PR-BSI), with a focus on clinical symptoms. The results showed that fever and chills were factors associated with the occurrence of PR-BSI.

ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2023)

Article Infectious Diseases

Effect of Tocilizumab on Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta or Omicron Variants: A Propensity-Matched Analysis in Nimes University Hospital, France

Paul Laffont-Lozes, Didier Laureillard, Paul Loubet, Robin Stephan, Myriam Chiaruzzi, Edouard Clemmer, Aurelie Martin, Claire Roger, Laurent Muller, Pierre-Geraud Claret, Radjiv Goulabchand, Clarisse Roux, Jean-Philippe Lavigne, Albert Sotto, Romaric Larcher

Summary: We conducted a prospective cohort study to assess the factors associated with mortality in patients with SARS-CoV-2 pneumonia treated with tocilizumab. Our results showed that age, Charlson index, WHO-CPS, and early administration of tocilizumab were independently associated with mortality. There was no significant difference in mortality between patients treated with tocilizumab and standard of care alone, but better survival was observed in patients who received tocilizumab within 48 hours of hospital admission.

ANTIBIOTICS-BASEL (2023)

Article Infectious Diseases

Outcomes of Beta-Lactam Allergic and Non-Beta-Lactam Allergic Patients with Intra-Abdominal Infection: A Case-Control Study

Tayma Naciri, Boris Monnin, Alix Pantel, Claire Roger, Jean-Marie Kinowski, Paul Loubet, Jean-Philippe Lavigne, Albert Sotto, Romaric Larcher

Summary: This study compared the outcomes of beta-lactam allergic (BLA) patients and non-beta-lactam allergic (NBLA) patients with intra-abdominal infections (IAI). The results showed that BLA patients treated without beta-lactam had the same treatment outcomes as NBLA patients treated with beta-lactam.

ANTIBIOTICS-BASEL (2022)

Article Microbiology

Clinical Features and Outcomes of Enterococcal Bone and Joint Infections and Factors Associated with Treatment Failure over a 13-Year Period in a French Teaching Hospital

Aurelie Martin, Paul Loubet, Florian Salipante, Paul Laffont-Lozes, Julien Mazet, Jean-Philippe Lavigne, Nicolas Cellier, Albert Sotto, Romaric Larcher

Summary: This study describes the clinical characteristics and treatment outcomes of patients with enterococcal bone and joint infections and identifies factors associated with treatment failure. The study found that enterococcal BJIs have poor prognosis, with a treatment failure rate of 39%. Coinfection with Staphylococcus epidermidis and the presence of local signs of inflammation at the time of diagnosis were identified as risk factors for treatment failure.

MICROORGANISMS (2023)

Article Respiratory System

CT features of community-acquired pneumonia at the emergency department

Marie Pierre Debray, Marie France Carette, Paul Loubet, Blandine Pasquet, Nadhira Houhou Fidouh, Mikhael Benjoar, Emmanuelle Varon, Anne Laure Brun, Yann Erick Claessens, Xavier Duval, Antoine Khalil

Summary: This study describes the different patterns of CAP in chest CT and finds that lobar pneumonia and lobular pneumonia are the most common patterns. Compared to other patterns, lobar pneumonia is less likely to be missed on CXR. Therefore, chest CT is very useful in identifying CAP.

RESPIRATORY MEDICINE AND RESEARCH (2022)

Article Medicine, General & Internal

Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial

Cecile Janssen, Marine Cachanado, Laetitia Ninove, Marie Lachatre, Jocelyn Michon, Olivier Epaulard, Zoha Maakaroun-Vermesse, Christian Chidiac, Bruno Laviolle, Hugues Aumaitre, Ady Assaf, Karine Lacombe, Catherine Schmidt-Mutter, Elisabeth Botelho-Nevers, Magali Briere, Thomas Boisson, Paul Loubet, Boris Bienvenu, Olivier Bouchaud, Amel Touati, Christine Pereira, Alexandra Rousseau, Laurence Berard, Melissa Montil, Xavier de Lamballerie, Tabassome Simon, Odile Launay

Summary: The study aimed to compare the immune response induced by heterologous and homologous SARS-CoV-2 mRNA vaccinations. Results showed higher levels of neutralizing antibodies with heterologous vaccination, but also more severe adverse reactions.

ECLINICALMEDICINE (2022)

Article Respiratory System

In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017-2019: an observational study

Alexandre Descamps, Nezha Lenzi, Florence Galtier, Fabrice Laine, Zineb Lesieur, Philippe Vanhems, Selilah Amour, Anne-Sophie L'Honneur, Nadhira Fidouh, Vincent Foulongne, Gisele Lagathu, Xavier Duval, Corinne Merle, Bruno Lina, Fabrice Carrat, Odile Launay, Paul Loubet

Summary: This study describes the clinical characteristics and outcomes of RSV infection in adults hospitalized with influenza-like illness, compared to patients admitted for influenza. The results show that RSV infection results in worse in-hospital outcomes compared to influenza, but similar post-discharge outcomes.

EUROPEAN RESPIRATORY JOURNAL (2022)

暂无数据